Recent Headlines
Biopontis Alliance Fund and Rosa Announce Strategic Relationship for Early Stage Drug Development
Collaboration will combine Rosa’s PhysioPD™ modeling & simulation capabilities with Biopontis’ innovative asset sourcing and financial structure to improve early drug development productivity. - February 07, 2012 - Rosa & Co LLC
Dr. Hartmut Derendorf to Discuss PK/PD-based Drug Development in Rosa’s World-Wide Webinar Series, “Impact of Modeling & Simulation in Drug Development”
Dr. Derendorf, will present “PK/PD-based Development of Anti-infective Agents” February 13, 2012. - February 06, 2012 - Rosa & Co LLC
Rosa to Present at 2012 Keystone Symposia: Cancer and Metabolism
Modeling analysis enables understanding efficacy of large numbers of potential drug combinations. - February 03, 2012 - Rosa & Co LLC
Mitutoyo Introduces World’s First 0.1µm Micrometer
Mitutoyo America Corporation introduces the first micrometer to offer 0.1µm resolution measurement. The High-Accuracy Digimatic® Digital Micrometer is available in a convenient, hand-held tool. - February 02, 2012 - Mitutoyo America Corporation
Advanced Cancer Therapeutics Chief Scientific Officer to Present Preclinical Data on Glycolysis Inhibitors at World Cancer Metabolism Summit
Advanced Cancer Therapeutics, LLC (ACT), a for-profit private company dedicated to bringing new anti-cancer therapies to market, today announced that Dr. Gilles Tapolsky, ACT’s Chief Scientific Officer, has been selected to present at the World Cancer Metabolism Summit to be held February 1 – February 2, 2012 in Washington, D.C. - February 01, 2012 - Advanced Cancer Therapeutics
FDA Clears ASI’s GenASIs Advanced Imaging for UroVysion Analysis
GenASIs Scan & Analysis cleared for FISH Detection and Analysis of chromosomal abnormalities in urine specimens. - February 01, 2012 - Applied Spectral Imaging
Roberto Clemente Health Clinic to Host Health Care Fair
Hundreds of residents who live in the remote communities of southwest Nicaragua will receive free healthcare at the Roberto Clemente Health Clinic’s Annual Health Care Fair from 9 a.m. to 2 p.m. on Saturday, February 4, in Limon 1 Tola, Rivas, Nicaragua. A team of more than 30 medical... - January 31, 2012 - The Roberto Clemente Health Clinic
Dr. Mike Reed to Participate in Roundtable Panel of American Society of Phamacometrics
Industry Presenters Will Focus on the Use and Benefits of Physiologic, Mechanistic Models in Drug Development - January 30, 2012 - Rosa & Co LLC
Colorado’s Bioscience Industry Leaders and Legislators Focus on 2012 Initiatives at Annual "BioScience Day at the Capitol"
Colorado BioScience Association (CBSA) is hosting its fourth annual "BioScience Day at the Capitol" on February 2. The CBSA is building upon one of its most successful years in its history, making impressive strides in the areas of industry advocacy, programming, marketing communications, membership and education. - January 30, 2012 - Colorado BioScience Association
Clinical Trials GPS Shares 2011 Q4 Findings; Almost 40% of Trials Aimed at Seniors, Less Than 17% Funded by the Government
Internal data shows a trend towards female participants, a surprisingly low volume of smokers, majority are willing to stay overnight, and an average age of 42. - January 27, 2012 - Clinical Trials Institute
Pfizer and Rosa to Present at 2012 Keystone Symposia: Pathogenesis of Diabetes
Insulin degradation and the mechanisms controlling it have significant impact on glucose homeostasis and diabetes. - January 26, 2012 - Rosa & Co LLC
Clinical Financial Services (CFS) Expands Internationally with Office in Edinburgh, Scotland
Clinical Financial Services, LLC (CFS), a specialty service provider focused on the business and financial management activities for clinical trials, has expanded its global presence by opening a new office in Edinburgh, Scotland. April Mulroney, CA, CPA, having most recently served as Vice... - January 26, 2012 - Clinical Financial Services
Clinical Trials GPS Highlights New Diabetes Trials; Aims to Help the Over 25 Million Individuals in U.S. Affected by Diabetes
25.8 million children and adults in the United States - 8.3% of the population - have diabetes. This equates to $116 billion in direct medical costs, and another $58 billion in indirect costs. - January 25, 2012 - Clinical Trials Institute
Health IT Startup TrialX Wins NCI’s Developer Challenge for Cancer App
TrialX, an NYC based health IT company was declared a winner of a developer challenge organized by the National Cancer Institute for its application, Ask Dory. Ask Dory helps cancer patients find and connect with clinical trials near them effortlessly. - January 25, 2012 - Applied Informatics
Rosa’s Toufigh Gordi to Present at 2nd Annual Pediatric Pharmacology Conference 2012
Integration of PK/PD and mechanistic physiological models improves drug development in infants. - January 24, 2012 - Rosa & Co LLC
New, Interactive Social Media Fundraising Campaign, Arrest ALS, Launched
Innovative fundraising concept leverages social media to raise money and awareness to end ALS. - January 22, 2012 - ALS Therapy Development Institute
BioRegenerative Sciences, Inc. Signs Memorandum of Understanding with Nurture Earth Pvt. Ltd. to Form Stem Cell Joint Venture in India
BioRegenerative Sciences, Inc. of San Diego, CA signs MOU with Nurture Earth, Pvt., Ltd. of India to form joint venture called BioRegenerative Sciences India (BRS India). The new joint venture, BRS India will produce, test, register, and market and sell BRS' stem cell-based therapeutic products in the Asian markets. - January 20, 2012 - BioRegenerative Sciences, Inc.
Life Vessel of the Prairie Announces Grand Opening in Wichita, Kansas
Life Vessel of the Prairie, houses the Life Vessel®, a patented, 510K FDA cleared non-invasive technology and technique by which frequency, vibration, sound and light waves are non-invasively applied to the human body in a resonance chamber, resulting in the body being able to perform its innate natural ability to heal itself. - January 17, 2012 - Hansa Center for Optimum Health
SignaBlok Awarded DARPA Contract to Support New Technology to Combat Sepsis
SignaBlok, Inc., a Massachusetts-based biopharmaceutical startup, has been awarded a contract from the Defense Advanced Research Projects Agency (DARPA) to introduce company’s new approach to the prevention and treatment of sepsis (blood poisoning). - January 12, 2012 - SignaBlok, Inc.
KDL Pathology Receives College of American Pathologists Accreditation
KDL Pathology | Knoxville Dermatopathology Lab announced today that its CLIA-registered laboratory has been accredited by the College of American Pathologists (CAP) following a recent onsite inspection by the Accreditation Committee of CAP. The CAP Accreditation Program is generally recognized as... - January 11, 2012 - KDL Pathology
Applied Spectral Imaging Announces the Launch of the GenASIs Automated Imaging Platforms for Genetic and Pathology Analysis
The GenASIs advanced cytogenetic and pathology platforms are the foundation of ASI’s new offering. With its superior imaging and analysis capabilities, ASI provides state of the art diagnostic aids, offering cytogeneticists and pathologists accurate genetic and pathology analysis. - December 24, 2011 - Applied Spectral Imaging
TTC Study Points to Increasing Clinical Trial Costs in New Geographies
Cost Per Patient on the Rise in Australia, Eastern Europe, and Latin America - December 23, 2011 - TTC LLC
Fitzsimons Redevelopment Authority Announces Second Phase of Strategic Refocus with $8 Million Expansion to Bioscience Park Center with 37,000-Square-Foot Accelerator
The Fitzsimons Redevelopment Authority (FRA) is expanding its Bioscience Park Center (BPC) by roughly 50% with an $8 million, 37,000-square-foot accelerator structure. The new accelerator space will be leased to existing tenants graduating from the incubator and other companies in the modest growth stage. - December 12, 2011 - Fitzsimons Redevelopment Authority
SFL’s Public Affairs Now Covers Bioethics
SFL’s Public Affairs team, helping organizations shape EU rules, saw exciting expansion in 2011. - December 11, 2011 - SFL Regulatory Affairs & Scientific Communication Ltd
CoreTherm Medical, Inc. Expand Mobilizer Business by Signing Paul Almaguer in Dallas
CoreTherm Medical, Inc., today announced that they have signed a contract with Dallas/Ft Worth area-based Paul Almaguer to become a new mobilizer for their CoreTherm® system. - December 10, 2011 - CoreTherm Medical Inc.
Mitutoyo America Corporation Announces New President
Mitutoyo America Corporation has appointed Shigeyuki Sasaki as the new President of the organization, effective immediately. - December 09, 2011 - Mitutoyo America Corporation
Colorado BioScience Association Celebrates 2011 Industry Standouts
The Colorado BioScience Association (CBSA) honored the outstanding bioscience companies and individuals in the state during its 9th Annual Awards Dinner at the Downtown Denver Embassy Suites. The CBSA's Annual Awards program showcases the significant achievements in the state's bioscience industry throughout the year. - December 09, 2011 - Colorado BioScience Association
SFL Thanks Clients and Partners for Successful Collaborations
With the end of 2011 approaching, SFL can reflect on a very successful year of extension and expansion in all areas. The company’s client base has expanded internationally as demand has grown for its personalized and comprehensive services in the fields of Regulatory Affairs, Public Affairs, Legal Services and Medical Communication. - December 08, 2011 - SFL Regulatory Affairs & Scientific Communication Ltd
Pipette.com Now Has ISO 9001 and ANSI/NCSL Z540.3 Accreditation to Compliment the Existing ISO 17025 Accreditation for Pipette Calibration
Pipette.com is excited to announce the attainment of ISO 9001:2008 certification and ANSI/NCSL Z540-1-1994 accreditation on top of existing ISO 17025:2005 Accreditation. The ISO 17025 and ANSI/NCSL Z540.3-2006 accreditations were issued by A2LA. The ISO 9001 accreditation was issued by QAS... - December 04, 2011 - Accutek Laboratories
Thermo Fisher Scientific Announces New Thermo Scientific Orion Meters
An entirely new expanded offering means no settling – get the right meter for the right application. - November 30, 2011 - Thermo Scientific
Clinical Trials GPS Launches Nationwide Patient Recruitment Site
Clinical Trials GPS was created to provide individuals with the most comprehensive, up to date information about ongoing clinical drug trials, as well as a quick and easy way to participate. - November 29, 2011 - Clinical Trials Institute
GenWay Biotech Launches Cardiovascular Diagnostic Blood Test at American Heart Association Scientific Sessions 2011 First Multiple Biomarker Test to Predict Near Term MI
FirstMark, the diagnostic division of GenWay Biotech, Inc., today announced study results and the commercial launch of PREventTM. FirstMark PREvent is the first multiple biomarker test that accurately predicts near term (approximately 2-3 years) risk of myocardial infarction for suspected or confirmed coronary artery disease (CAD) patients. FirstMark PREvent is now available and will be targeted to primary care physicians and cardiologists. - November 24, 2011 - GenWay Biotech
Mitutoyo HR Series Hardness Testing Machines Raise the Bar for Value
Mitutoyo America Corporation's new HR-200/300/400/500 Series Rockwell hardness testing machines offer enhanced performance with improved frames, better ergonomics and additional productivity boosting features. - November 22, 2011 - Mitutoyo America Corporation
Fertility Preservation Network Sponsors Fall Cancer Fundraising Events
ReproTech, Ltd., a cryobank specializing in long-term storage of human reproductive tissue (sperm, eggs, embryos and ovarian/testicular tissue), was a sponsor in recent fundraising events to benefit the Pancreatic Cancer Action Network (PANCAN). - November 16, 2011 - ReproTech, LLC
Fitzsimons Redevelopment Authority Rolls Out First Phase of Strategic Refocus with Appointment of Four Key Leaders in the Bioscience Industry to Its Board of Directors
The Fitzsimons Redevelopment Authority (FRA) is adding four of the area's most well-known and successful leaders in the Bioscience Industry to its Board of Directors. Change in board composition is the result of a strategic refocus for the FRA, and those recently appointed to the board include: Donald M. Elliman, Jr.; William Freytag, PhD; James C. T. Linfield; and David Perez. - November 15, 2011 - Fitzsimons Redevelopment Authority
Photo Exhibit by Colorado BioScience Association Keynote Speaker Rick Guidotti Begins Friday, November 18, at VSA Colorado/Access Gallery, Santa Fe Arts District
Photos by Colorado BioScience Association (CBSA) Awards Dinner Keynote Presenter Rick Guidotti will be on display for a month, beginning November 18, at Denver's CSA Colorado/Access Gallery in the Santa Fe Arts District. Guidotti, award winning fashion photographer, is known worldwide for his dynamic images and important message about genetic difference. - November 14, 2011 - Colorado BioScience Association
Rosa to Provide Noncompartmental Pharmacokinetic Analyses NCAs for Advanced Research Institute
Integration Creates Seamless Data Management and Analysis Capability for ARA Customers - November 14, 2011 - Rosa & Co LLC
Mitegen Announces Distribution Agreement with Helix Biotech in Malaysia
Mitegen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, announced that it has signed a distribution agreement with Helix Biotech (M) SDN BHD of... - November 12, 2011 - MiTeGen, LLC
Mitegen Announces Mutual Distribution Agreements with AJK Analytical Services
Mitegen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, announced that it has signed mutual distribution agreements with AJK Analytical Services. - November 12, 2011 - MiTeGen, LLC
Announcing the Release of a Novel Tool for the Assessment of Porcine Islet Functionality: the Mercodia Porcine C-peptide ELISA
Mercodia announced the release of their new Porcine C-Peptide ELISA at the recent Cell Transplant Society (CTS) and International Xenotransplantation Association (IXA) meeting in Miami, Florida, October 23-26. This assay provides the type 1 diabetes, and more specifically the islet transplantation,... - November 10, 2011 - Mercodia Inc.
Colorado BioScience Association Launches Internship Program with Support of 11 Area Employers and Universities
The Education Committee of the Colorado BioScience Association (CBSA) is launching its new Internship Program with the support of 11 Founding Employers and the major universities in the state. Intern recruitment begins immediately through early spring 2012, with the first interns expected to be placed in positions by summer 2012. - November 10, 2011 - Colorado BioScience Association
Total Pipette Management (TPM) Makes Compliance Easy with Green Document Storage Solutions and 24/7 Access for Pipette Calibration Records
Pipette.com is excited to announce the availability of Total Pipette Management (TPM) an innovative software solution to manage all aspects of a pipette instrument population. TPM is best known for its uses with document management for pipette calibration. TPM stores calibration certificates... - November 04, 2011 - Accutek Laboratories
No-Risk Prenatal Paternity Testing Provides Peace of Mind, Answering Important Questions Before Your Child’s Birth
ANY LAB TEST NOW-Wichita Falls is at the forefront of DNA family relationship testing, now offering a prenatal paternity test from blood collected from the pregnant mother and alleged expectant father. - November 03, 2011 - Any Lab Test Now
VP at OSO BioPharmaceuticals Elected to DCAT Board of Directors
Milton Boyer to serve three-year term at leading industry association. - November 03, 2011 - OSO BioPharmaceuticals Manufacturing, LLC
National Testing Laboratories, Ltd Achieves ISO 17025:2005 Accreditation
National Testing Laboratories, Ltd conveys commitment to the highest quality water testing services for our customers through ISO 17025:2005 accreditation. - November 03, 2011 - National Testing Laboratories, Ltd
Mitegen Announces Mutual Distribution Agreements with XTalQuest Inc., Ltd.
Mitegen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, announced that it has signed mutual distribution agreements with XTalQuest Inc., Ltd a Beijing based provider of high quality crystallization plates, screening solutions, and other products for crystallography. - November 01, 2011 - MiTeGen, LLC
Dr. Mike Reed Joins Rosa & Co. Executive Management Team
Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation, today announced the appointment of Mike Reed as Vice President. - November 01, 2011 - Rosa & Co LLC
DNA Diagnostics Centre UK Launches Groundbreaking Non-Invasive Prenatal Paternity Test – The Only Company Offering Test in UK
DNA Diagnostics Centre (DDC), the UK’s leading company for DNA paternity and relationship testing, announced today that DDC is the only company offering the first non-invasive prenatal paternity test in the UK. The new test uses SNP Microarray Technology, which requires only a simple blood sample collection from both the mother and alleged father. - October 28, 2011 - DNA Diagnostics Centre
Colorado BioScience Association Hosts World Renowned Photographer Rick Guidotti for Keynote Presentation at Industry Awards Celebration in Denver
Registration is now open for the Colorado BioScience Association (CBSA) Annual Awards Dinner, featuring Keynote Presenter Rick Guidotti, world renowned photographer and co-founder of New York-based Positive Exposure. The CBSA awards event is Thursday, December 8, at the Embassy Suites in Downtown Denver. - October 27, 2011 - Colorado BioScience Association
Bedford Research Foundation Hosts Ninth Annual Activated Egg Symposium
The Bedford Research Foundation is hosting the ninth annual Activated Egg Symposium, a yearly event that brings together experts in the stem cell research community to discuss their work, and form collaborations. The foundation's director, Dr. Ann Kiessling is proud to announce that this year's keynote speaker is Dr. Janet Rossant of the University of Toronto. The event is on November 4th, 2011 from 8am to 7:30pm. - October 26, 2011 - Bedford Stem Cell Research Foundation